The role of sex in the life cycle and transmission of Pneumocystis
性在肺孢子虫生命周期和传播中的作用
基本信息
- 批准号:10350565
- 负责人:
- 金额:$ 48.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAnidulafunginAntifungal AgentsBiological AssayBiological MarkersCell CycleChronicClinicalCompetenceComplexDataDiagnosisDoseElectron MicroscopyElectronsEvaluationExposure toGene ExpressionGenesHIVImmunocompromised HostImmunotherapyInfectionInterruptionLeadLife Cycle StagesLungMalignant NeoplasmsMass Spectrum AnalysisMeasurementMethodsMicrobeMicroscopicModelingMorphologyMusOrganismOutcomePartner in relationshipPatientsPharmaceutical PreparationsPhasePneumocystisPneumocystis cariniiPneumoniaPopulationProliferatingProphylactic treatmentProteinsProteomicsReportingRheumatoid ArthritisRoleSeriesSexual TransmissionSignal TransductionTechniquesTimeWithdrawalasexualbasefungusgenetic signaturemouse modelnovelnovel therapeuticspathogenic funguspneumonia treatmentpolyglucosanpotential biomarkerpreventprophylacticsexsexual roletargeted agenttherapeutic targettooltransmission processtreatment duration
项目摘要
Pneumocystis spp. are host obligate fungal pathogens that cause a fatal pneumonia (PCP) in
immunocompromised hosts. Few drugs are effective against PCP and there have been no new therapies for its
treatment in decades. PCP remains a problem in HIV-infected patients and is emerging as a clinical concern in
newly susceptible populations including patients receiving immunotherapy for chronic conditions.
We recently reported that treatment of PCP in murine models with the echinocandins, anti-fungal agents that
target β-1,3-D-glucan synthesis (BG), depleted the asci which contain BG, but large numbers of forms that do
not express BG remained in the infected lungs and were apparently unable to proliferate. Notably, the treated
mice could not transmit the infection without asci. The echinocandins prevented PCP when administered
prophylactically at higher doses, suggesting that formation of asci via the sexual cycle may be required for a
productive infection. Genes associated with sexual replication and cell cycle perturbation comprised the
strongest up-regulated signals in P. murina from anidulafungin treated mice. These infections were devoid of
asci, suggesting that P. murina attempted to undergo sexual replication, but could not due to a lack of BG.
Based on these data, we posit that asci, and thus sexual replication, is required for progression through
the Pneumocystis life cycle. The importance of the sexual cycle for survival of Pneumocystis will be
investigated using the anidulafungin treatment and prophylactic models. The specific aims address 2 major
questions we propose to pursue: Question 1: Is sexual replication required for completion of the life cycle
of Pneumocystis? 3 aims will be used to address this question. The first will be to assess the replication
competency of P. murina treated with anidulafungin by transferring them to new hosts. Replication will be
determined by a combination of microscopic methods, BG measurement, and quantitative PCR. The second
aim will use the prophylactic model to allow low level replication to ask whether replication occurs via the sexual
cycle, using the same methods. The third aim will determine whether P. murina can survive during prolonged
anidulafungin treatment in the same hosts without proceeding through the sexual cycle or if it is eventually
cleared. Question 2: At what point in the Pneumocystis life cycle can the infection be transmitted? The
sexual cycle returns after withdrawal of anidulafungin. During 10 days to 4 weeks post-cessation, we will track
the emergence of the sexual cycle and identify gene signatures, biomarkers and numbers of asci prior to
exposing these mice to naïve recipients. Using these data, we will determine at what point in the life cycle
transmission takes place and the thresholds necessary for transmission. Selected proteins based on gene
expression data will be validated by proteomics as potential biomarkers associated with return of the sexual
cycle and transmission. These studies will identify potential vulnerabilities in the Pneumocystis life cycle that
could be exploited for interdiction and add to our understanding of its life cycle and transmission.
肺囊虫是宿主专性真菌病原体,可引起致命性肺炎(PCP)
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melanie T Cushion其他文献
Melanie T Cushion的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melanie T Cushion', 18)}}的其他基金
The role of sex in the life cycle of Pneumocystis
性在肺孢子虫生命周期中的作用
- 批准号:
10047702 - 财政年份:2018
- 资助金额:
$ 48.82万 - 项目类别:
The role of sex in the life cycle of Pneumocystis
性在肺孢子虫生命周期中的作用
- 批准号:
10421251 - 财政年份:2018
- 资助金额:
$ 48.82万 - 项目类别:
International Workshop on Opportunistic Protists (IWOP-14)
机会性原生生物国际研讨会(IWOP-14)
- 批准号:
9398434 - 财政年份:2017
- 资助金额:
$ 48.82万 - 项目类别:
Directed Culturing of Pneumocystis Using Metatranscriptomics
利用宏转录组学定向培养肺孢子虫
- 批准号:
8664916 - 财政年份:2013
- 资助金额:
$ 48.82万 - 项目类别:
Directed Culturing of Pneumocystis Using Metatranscriptomics
利用宏转录组学定向培养肺孢子虫
- 批准号:
8554433 - 财政年份:2013
- 资助金额:
$ 48.82万 - 项目类别:
Immunopathology of the Pneumocystis Life Cycle Stages
肺孢子虫生命周期阶段的免疫病理学
- 批准号:
8397516 - 财政年份:2010
- 资助金额:
$ 48.82万 - 项目类别:
Immunopathology of the Pneumocystis Life Cycle Stages
肺孢子虫生命周期阶段的免疫病理学
- 批准号:
7929730 - 财政年份:2010
- 资助金额:
$ 48.82万 - 项目类别:
Immunopathology of the Pneumocystis Life Cycle Stages
肺孢子虫生命周期阶段的免疫病理学
- 批准号:
8195572 - 财政年份:2010
- 资助金额:
$ 48.82万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 48.82万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 48.82万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 48.82万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 48.82万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 48.82万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 48.82万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 48.82万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 48.82万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 48.82万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 48.82万 - 项目类别:
Research Grant